FDA Inspection 1300470 - Matthew Brimberry, MD - January 30, 2026

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Record Details

This FDA Inspection record concerns Matthew Brimberry, MD, with an inspection on January 30, 2026, issued by the Dallas District Office, covering human drugs.

Company: Matthew Brimberry, MD
Inspection Date: January 30, 2026
Product Type: Human Drugs
Office: Dallas District Office

Open in Dashboard

ID · bb43c471-e58c-49cc-9a4c-2413bd105e1f

Violation Codes1

21 CFR 312.60

Full citation text and observation details available on the Dashboard.